Product and Service [Axis] Patient services [Member] Pharmaceuticals [Member] Equity Components [Axis] Common Stock [Member] Retained Earnings [Member] Other comprehensive income [Member] Additional paid-in capital [Member] Non-Controlling Interest [Member] Ownership [Axis] Subsidiary, Runteng Medical Group Co., Ltd [Member] JRSIS Health Care Limited [Member] Legal Entity [Axis] Runteng [Member] Junsheng Zhang [Member] Income Statement Location [Axis] Revenue And Expenses [Member] Currency [Axis] China, Yuan Renminbi Hong Kong, Dollars Balance Sheet Location [Axis] Assets And Liabilities [Member] Property, Plant and Equipment, Type [Axis] Building And Building Improvements [Member] Range [Axis] Minimum [Member] Maximum [Member] Medical Equipment [Member] Transportation Equipment [Member] Office Equipment And Others [Member] Electronic Equipment [Member] Software [Member] Concentration Risk Benchmark [Axis] Sales Revenue, Net [Member] Accounts Receivable [Member] Income Tax Authority, Name [Axis] People's Republic of China [Member] Inventory [Axis] Chinese Herbal Medicine [Member] Medical Material [Member] Other Material [Member] Prepayment [Axis] Heating Fees [Member] Others [Member] Buildings [Member] Jiarun [Member] Product [Member] Health Care Organization Revenues [Axis] Chinese Medicine [Member] Herbal Medicine [Member] Service [Member] Medical Consulting [Member] Medical Treatment [Member] Harbin Baiyi Real Estate Development Co., Ltd [Member] Harbin Jiarun Pharmacy Co Ltd [Member] Junsheng Zhang [Member] Yanhua Xing [Member] Weiguang Song [Member] Harbin Jiarun Pharmacy Co Limited [Member] Heilongjiang Province Runjia Medical Equipment Company Limited [Member] Jiarun Super Market Co Limited [Member] Harbin Qirun Pharmacy Co Limited [Member] Related Party [Axis] Lease Arrangement Type [Axis] Operating Lease [Member] Finance Lease [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Non-Cancellable Operating Lease Agreements [Member] Sale and Leaseback Agreement [Member] Haitong Hengxin International Leasing Company Limited [Member] Lease Agreements [Member] Unrelated Third Parties [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Western Pharmaceuticals [Member] Geographical [Axis] UNITED STATES HONG KONG CNY Deposits on Medical Equipment [Member] Other Comprehensive Income [Member] Additional Paid-in Capital [Member] Non-controlling Interest [Member] Document And Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Document Type Trading Symbol Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Emerging Growth Company Entity Small Business Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current Assets: Cash and cash equivalents Accounts receivable, net Inventories Other receivables Prepayments Amount due from related parties Deferred expenses Deposits for capital leases-current portion Total current assets Construction in progress Property and equipment, net Long term deferred expenses Deposits for capital leases Right-of-use assets Total assets Liabilities and shareholders' equity Current Liabilities: Accounts payable Notes payable Deposits received Amount due to related parties Other payable Deferred tax payable-current Tax payable Payroll payable Lease obligation-current portion Total current liabilities Deferred tax payable Lease obligation Other capital lease payable Total liabilities Shareholders' equity Common stock; $0.001 par value, 100,000,000 shares authorized; 14,975,000 and 14,975,000 issued and outstanding at March 31, 2019 and December 31, 2018, respectively Additional Paid-in capital Retained earnings Other comprehensive income Total shareholders' equity of the Company Non-controlling interest Total shareholders' equity Total liabilities and shareholders' equity Common Stock, Par or Stated Value Per Share (in dollars per share) Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Statement [Table] Statement [Line Items] Revenue: Total revenue Operating costs and expenses: Cost of pharmaceuticals sold Medical consumables Salaries and benefits Office supplies Vehicle expenses Utilities expenses Operating leases expense Advertising and promotion expenses Professional fee Depreciation and amortization Total operating costs and expenses Earnings from operations before other income and income taxes Other income Earnings from operations before income taxes Income tax Net income Less: net income attributable to non-controlling interests Net income attributable to the Company Comprehensive income: Foreign currency translation adjustment Foreign currency translation adjustment attributable to non-controlling interests Foreign currency translation adjustment attributable to the Company Comprehensive income Less: Comprehensive income attributable to non-controlling interests Comprehensive income attributable to the Company Basic and diluted earnings per share Weighted average number of shares outstanding Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance in beginning Balance in beginning (in shares) Net income Shares issued Shares issued (in shares) Balance in end Balance in end (in shares) Statement of Cash Flows [Abstract] Cash Flows From Operating Activities Adjustments to reconcile net income to net cash provided by operating activities: Depreciation Changes in operating assets and liabilities: Accounts receivable, net Inventories Amount due from related parties Prepayments and other current assets Accounts payable Amount due to related parties Deposits received Accrued expenses and other current liabilities Net cash provided by operating activities Cash Flows From Investing Activities Purchases of property and equipment Prepayment for property and equipment acquisition Payment of Construction in progress Net cash (used in) investing activities Cash Flows From Financing Activities Proceeds from shareholders Payments of finance lease obligations Interest Short-term bank loan Proceeds from finance lease Net cash provided by (used in) financing activities Effect of exchange rate fluctuation on cash and cash equivalents Net increase in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, ending of period Supplemental disclosure of cash flow information Cash paid for income taxes Cash paid for interest Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF BUSINESS AND ORGANIZATION Accounting Policies [Abstract] SUMMARIES OF SIGNIFICANT ACCOUNTING POLICIES Receivables, Net, Current [Abstract] Accounts Receivable, Net Inventory Disclosure [Abstract] Inventories Prepaid Expense, Current [Abstract] Prepayment Property, Plant and Equipment [Abstract] Property and Equipment Deferred Expenses [Abstract] Long term deferred expenses Leases [Abstract] Right-of-Use Assets and Lease Liabilities Noncontrolling Interest [Abstract] Non-controlling Interests Revenues [Abstract] Revenue Income Tax Disclosure [Abstract] Income Tax Expense Related Party Transactions [Abstract] Related Party Transactions Earnings Per Share [Abstract] Basic and Diluted Earnings Per Share Commitments and Contingencies Disclosure [Abstract] Contingencies and Commitment Subsequent Events [Abstract] Subsequent Events Basis of presentation Principles of consolidation Use of estimates Functional currency and foreign currency translation Concentration of Credit Risk Cash and cash equivalents Accounts receivable Inventories Construction in progress Property and equipment Leases Fair Value Measurement Segment and geographic information Revenue recognition Income taxes Earnings per share Reclassification Recently adopted accounting pronouncements Schedule of foreign currency translation Schedule of estimated useful lives for property and equipment categories Schedule of accounts receivable net Schedule of Inventories Schedule of prepayment Schedule of property and equipment Schedule of unaudited condensed consolidated balance sheet Schedule of future minimum lease payments for annual capital lease obligation Schedule of Future annual minimum lease payments, for non-cancellable operating leases Schedule of right-of-use assets Schedule of revenue Schedule of due from related parties Schedule of due to related parties Schedule of purchases from related party transactions Schedule of basic and diluted earnings per share Business And Organization [Table] Business And Organization [Line Items] Subsidiary, Runteng Medical Group Co., Ltd [Member] Joint venture investment in Jiarun, Ownership Percentage in Harbin Jiarun Hospital Co., Ltd Joint venture investment in jiarun, Registered Capital Noncontrolling Interest, Ownership Percentage by Parent Foreign currency translation Description of foreign currency translation Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Statistical Measurement [Axis] Property, Plant and Equipment, Useful Life Concentration Risk, Percentage Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Number of customers Accounts receivable Less: allowance for doubtful debts Accounts receivable, net Inventory, Current [Table] Inventory [Line Items] Total inventories Schedule Of Prepaid Expenses Current [Table] Schedule Of Prepaid Expenses Current [Line Items] Total prepayment Total fixed assets at cost Accumulated depreciation Reclass to Right-of-use assets Total fixed assets, net Depreciation expense Long-term deferred expenses Consulting fees Decoration fees Assets and Liabilities, Lessee [Abstract] Operating lease assets Finance lease assets Total Liabilities Current Operating lease liabilities Finance lease liabilities Long-term Operating lease liabilities Finance lease liabilities Total Capital leases 2019 2020 2021 Thereafter Total Year ending December 31 2019 2020 2021 2022 Total Schedule Of Capital Lease Obligations and Deposit for Capital Leases [Table] Schedule Of Capital Lease Obligations and Deposit for Capital Leases [Line Items] Lease Arrangement, Type [Axis] Lease assets Accumulated amortization Total right-of-use assets, net Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Lease Agreement Annual Payments Captial Lease Obligation Deposits (Financial Leasing Premium Payments) Term of Capital Lease Capital Lease Obligation Interest Rate Percentage Capital Lease Future Minimum Payments Fair Value Of Assets Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments Capital Lease Financing Fees Finance lease term Net value of properties Lease payments Lease payment term Additional net lease assets Additional net lease liabilities Operating lease expense Finance lease amortization expense Depreciation and amortization General property and equipment depreciation Operating lease expense included amortization expense Operating lease amortization expense Noncontrolling Interest [Table] Noncontrolling Interest [Line Items] Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Stockholders' Equity Attributable to Noncontrolling Interest Schedule of Product Information [Table] Product Information [Line Items] Revenue Income Tax Expense [Table] Income Tax Expense [Line Items] Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Income Tax Expense (Benefit) Tax deduction rate Purchase of equipment Deferred income tax Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Related party transaction, purchases from related party Extinguishment of Debt [Axis] Deposits for capital leases, ended of the period Capital lease obligations, ended of the period Numerator: Net income available to common stockholders Denominator: Basic and diluted weighted-average number of shares outstanding (in shares) Net income per share: Basic and diluted (in dollars per share) Stock dividend percentage Dividend record date Dividend issue date Description of conversion of stock Costs incurred and are directly related to medical consumables during the reporting period. Total costs related to goods produced and sold during the reporting period. Represents information related to deposits for capital leases current portion. Represents information related to pharmaceuticals. Utilities costs incurred during the reporting period for services, such as water, sewer, gas, electricity and telephone required to operate a building. Cost incurred during the reporting period in transporting goods and services to customers. Includes freight-out costs. Represents information related to proceeds from finance lease. Represents information related to proceeds from interest. Represents information related to right of use asset net noncurrent. Tabular disclosure for business and organization. Amount refers to business and organization. The member represent subsidiary runteng medical group co ltd. The member represent irsis health care limited. Represent the information related to subsidiary runteng medical group. Represent the information related to runteng. Represent the information related to junsheng zhang. Represents the value of investment as registered capital in joint venture investment. Represent the information related to reveneu and expences. Represent the information related to assets and liabilities. The entire disclosure for foreign currency translation. Represent the information related to medical euipment. Represent the information related to electrical equipment. Represent number of customers. Represent the information related to western medicine. Represent the information related to chinese herbal medicine. Represent the information related to medical material. Represent the information related to other material. Tabular disclosure for prepaid expences current. Tabular inforamtion related to prepaid expences current. Information by prepayment. Information by prepayment. Represent the information related to heating fees. Represent the information related to other. Amount refers to the reclass to right-of-use assets. Amount of expenses related to the Consulting Fee during the reporting period. Amount of expenses related to the decoration fee during the reporting period. Represent the information related to jiarun. Represent health care organization revenue. Represent health care organization revenue. Represent the information related to chinese medicine. Represent the information related to herbal medicine. Represent the information related to medical consulting. Represent the information related to medical treatment. Represent the information related to harbin baiy rela estate development. Represents information related to harbin jiarun pharmacy co Ltd. Represent the information related to junsheng zhang. Represent the information related to yanhu xing. Represent the information related to weiguang song. Represent the information related to harbin jiarun pharmacy. Represent the information related to heliongjing province runjia medical equipment company. Represent the information related to jiarun super market co. Represent the information related to harbin qirun pahrmacy. Tabular disclosure for basic and diluted earning per share. Amount referes to basic and diluted earning per share, Amountof total lease assets. Amount of liabilities lease. Tabular disclosure for capital lease obligations and deposit for capital leases. Tabulare information for capital lease obligation and deposite. Its represent the operating lease. Its represent the finance lease. Amount of lease assets. Amount of amortization expense attributable to right-of-use asset from lease. Represents information related to non cancellable operating lease agreements. Represents information related to sale and leaseback agreement. Represents information related to haitong hengxin international leasing company limited. Represents information related to unrelated third parties. This represents the annual payments related to lease agreements. This element represents that, the term of capital lease. It represent the value of capital lease obligation interest rate percentage. This represents the capital lease fair value of assets. The financing leases as of the balance sheet date consisting of: (a) minimum lease payments due on direct financing leases, (b) unguaranteed residual value, and (c) any unamortized initial direct costs; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments. Represents information related to net value of properties. Represents information related to lease payment term. Represents information related to additional net lease assets. Represents information related to additional net lease liabilities. Represents information related to operating lease expense included amortization expense. Represents information related to operating lease amortization expense. Represents information related to western pharmaceuticals. The entire disclosure for prepaid expenses current. The entire disclosure of long term deferred expenses. Health care organization revenues disclosure. Disclosure of accounting policy for construction in progress. Tabular disclosure of property plant and equipment useful life. Tabular disclosure of prepaid expenses current. Schedule of health care organization revenues. The entire disclosure of Schedule Of Due From related party transactions. The entire disclosure of Schedule Of Due To related party transactions. The entire disclosure of Schedule Of Purchases from related party transactions. Represents income tax expense table. Represents income tax expenses line items. Information about deposits on medical equipment. Junsheng Zhang [Member] [Default Label] Assets, Current Assets [Default Label] Liabilities, Current Liabilities [Default Label] Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Costs and Expenses Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net Income (Loss) Attributable to Parent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Due from Related Parties Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Due to Related Parties Increase (Decrease) in Deposits Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments for (Proceeds from) Investments Repayments of Advances for Construction Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Income Taxes Paid, Net Inventory Disclosure [Text Block] LongTermDeferredExpensesTextBlock Cash and Cash Equivalents, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] ConstructionInProgressPolicyTextBlock Subsidiary, Runteng Medical Group Co., Ltd [Member] [Default Label] Accounts Receivable, before Allowance for Credit Loss, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment ReclassToRightofuseAssets TotalLeaseAssets Operating Lease, Liability, Noncurrent Finance Lease, Liability, Noncurrent TotalLiabilitiesLease Capital Leases, Future Minimum Payments Due Operating Leases, Future Minimum Payments Due, Next Twelve Months Operating Leases, Future Minimum Payments, Due in Two Years Operating Leases, Future Minimum Payments, Due in Three Years Operating Leases, Future Minimum Payments Due RightOfUseAssetAccumulatedAmortization Depreciation, Depletion and Amortization, Nonproduction